Diploma PLC (LON:DPLM – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is GBX 7,400.
A number of analysts have commented on DPLM shares. Berenberg Bank reaffirmed a “buy” rating and set a GBX 9,000 price objective on shares of Diploma in a research note on Monday, July 20th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the stock a “buy” rating in a research report on Wednesday, May 20th. JPMorgan Chase & Co. boosted their price target on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a report on Monday. Jefferies Financial Group restated a “hold” rating and issued a GBX 7,000 price target on shares of Diploma in a research report on Friday, May 29th. Finally, Royal Bank Of Canada raised their price objective on shares of Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a research note on Friday, July 17th.
Read Our Latest Analysis on Diploma
Diploma Trading Up 1.5%
Insider Activity
In other Diploma news, insider Mandy Gradden purchased 1,000 shares of the stock in a transaction dated Friday, July 17th. The shares were acquired at an average price of GBX 7,183 per share, for a total transaction of £71,830. Also, insider Wilson Ng purchased 424 shares of the company’s stock in a transaction that occurred on Thursday, July 16th. The shares were acquired at an average cost of GBX 7,066 per share, for a total transaction of £29,959.84. Insiders acquired 1,604 shares of company stock worth $11,447,718 over the last quarter. Corporate insiders own 1.14% of the company’s stock.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Articles
- Five stocks we like better than Diploma
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
